Boobalan Pachaiyappan
Stock Analyst at Roth MKM
(0.51)
# 2423
Out of 5,331 analysts
10
Total ratings
50.00%
Success rate
-2.41%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CRVO CervoMed | Maintains: Strong Buy | 15 20 | 10.18 | 96.46% | 3 | Mar 18, 2025 | |
VRNA Verona Pharma | Initiates Coverage On: Buy | 68 | 72.73 | -6.5% | 1 | Jan 10, 2025 | |
RVPH Reviva Pharmaceutica... | Initiates Coverage On: Buy | 7 | 0.87 | 704.6% | 1 | Jan 10, 2025 | |
CING Cingulate | Initiates Coverage On: Buy | 12 | 4.34 | 176.5% | 1 | Jan 10, 2025 | |
GANX Gain Therapeutics | Maintains: Buy | 7 7 | 2.06 | 239.81% | 2 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 9.32 | 211.16% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.57 | 536.94% | 1 | Dec 5, 2024 |